image: Microscopy image of blood stem cells that will go through CRISPR/Cas9 gene editing in a lab dish. This material relates to a paper that appeared in the Jul. 31, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by O. Humbert at Fred Hutchinson Cancer Research Center in Seattle, WA; and colleagues was titled, "Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates." view more
Credit: Kiem lab/Fred Hutchinson Cancer Research Center